Product Specifications
| Catalog Number |
BIC-3584E |
| Target |
CD3 complex |
| Target Symbol |
CD3 |
| Endotoxin |
≤1 EU/mg by the LAL method. |
| Formulation |
Liquid |
| Buffer |
0.22 μm-filtered solution containing PBS, pH 7.4 |
| Storage & Stability |
24 months at -20°C to -80°C under sterile conditions; 6 months at 2°C to 8°C under sterile conditions; Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Bioactivity
Recombinant Anti-Human CD3 mAb (Cat. No. BIC-3584E) binding with Jurkat. The ED50 for this effect is less than 10 ng/mL.
Quality Data
Recombinant Anti-Human CD3 mAb (Cat. No. BIC-3584E) was analyzed by SDS-PAGE.
Recommended applications depend on the target, product format, and product-specific validation data. Refer to the product datasheet or Certificate of Analysis (CoA), or contact BioCrest Sci for application guidance.
Biological Activity: Recombinant Anti-Human CD3 mAb (Cat. No. BIC-3584E) binding with Jurkat. The ED50 for this effect is less than 10 ng/mL.
Storage: 24 months at -20°C to -80°C under sterile conditions; 6 months at 2°C to 8°C under sterile conditions; Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Shipping & Lead Time: Availability, shipping conditions, and estimated lead time are confirmed in the formal quotation or order confirmation based on the product format, destination, and order requirements.
